找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Artificial Oxygen Carrier; Its Frontline Koichi Kobayashi (Chief Professor of Surgery),Eish Conference proceedings 2005 Springer-Verlag Tok

[復(fù)制鏈接]
41#
發(fā)表于 2025-3-28 17:09:04 | 只看該作者
42#
發(fā)表于 2025-3-28 20:41:08 | 只看該作者
Isolation and Culture of Skin Fibroblastsing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
43#
發(fā)表于 2025-3-28 23:46:29 | 只看該作者
44#
發(fā)表于 2025-3-29 04:19:03 | 只看該作者
45#
發(fā)表于 2025-3-29 07:23:06 | 只看該作者
978-4-431-54636-8Springer-Verlag Tokyo 2005
46#
發(fā)表于 2025-3-29 12:24:26 | 只看該作者
Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes,s have been selected from the viewpoints of safety, efficacy, and cost performance. One is Hemoglobin-vesicles (HbV) and the other is albumin-heme (rHSA-heme). This chapter summarizes our video presentation that introduced the recent results of our research into HbV and rHSA-heme.
47#
發(fā)表于 2025-3-29 18:35:43 | 只看該作者
Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers,ing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
48#
發(fā)表于 2025-3-29 22:17:19 | 只看該作者
Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen,able to transport physiologically significant amounts of oxygen in animal experiments. Thus, the treatment sustained life in rats and pigs with potentially fatal erythrocytopenia caused by hemorrhage and hemodilution, and adequate oxygenation was preserved in severe right-to-left circulatory shunts caused by partial airway blockage in pigs.
49#
發(fā)表于 2025-3-29 23:57:52 | 只看該作者
50#
發(fā)表于 2025-3-30 06:44:50 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-24 11:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泗洪县| 三河市| 龙岩市| 泰和县| 新河县| 屯门区| 弥勒县| 壶关县| 泾阳县| 广昌县| 根河市| 敦煌市| 岳西县| 甘谷县| 临安市| 永康市| 岳西县| 茌平县| 阿拉善盟| 含山县| 天门市| 开远市| 城市| 鹤岗市| 娄底市| 思南县| 孟连| 库伦旗| 镶黄旗| 满城县| 三河市| 德令哈市| 平南县| 会东县| 奎屯市| 鄂托克旗| 从化市| 汶川县| 梁河县| 白银市| 子长县|